$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 19/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 19/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | M | 21.51 | 2,600 | 55,926 | 2,671 | |
| May 10 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 93.17 | 2,600 | 242,242 | 13,468 | 16.1 K to 13.5 K (-16.18 %) |
| May 10 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Buy | M | 21.51 | 2,600 | 55,926 | 16,068 | 13.5 K to 16.1 K (+19.31 %) |
| May 10 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 91.17 | 4,882 | 445,092 | 13,468 | 18.4 K to 13.5 K (-26.60 %) |
| May 10 2017 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Grant | A | 70.30 | 270 | 18,982 | 18,350 | 18.1 K to 18.4 K (+1.49 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | M | 17.33 | 7,500 | 129,975 | 0 | |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Buy | M | 17.33 | 7,500 | 129,975 | 34,260 | 26.8 K to 34.3 K (+28.03 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | M | 38.59 | 3,498 | 134,988 | 0 | |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | M | 28.23 | 988 | 27,891 | 0 | |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 99.00 | 3,498 | 346,302 | 51,532 | 55 K to 51.5 K (-6.36 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Buy | M | 38.59 | 3,498 | 134,988 | 55,030 | 51.5 K to 55 K (+6.79 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 99.00 | 988 | 97,812 | 51,532 | 52.5 K to 51.5 K (-1.88 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Buy | M | 28.23 | 988 | 27,891 | 52,520 | 51.5 K to 52.5 K (+1.92 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 38.59 | 2,500 | 96,475 | 39,844 | |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 100.34 | 2,500 | 250,853 | 85,251 | 87.8 K to 85.3 K (-2.85 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 38.59 | 2,500 | 96,475 | 87,751 | 85.3 K to 87.8 K (+2.93 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 70.30 | 302 | 21,232 | 85,251 | 84.9 K to 85.3 K (+0.36 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 37,423 | |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 42,423 | |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.17 | 5,000 | 465,850 | 238,496 | 243.5 K to 238.5 K (-2.05 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,496 | 238.5 K to 243.5 K (+2.10 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 99.00 | 5,000 | 495,000 | 238,496 | 243.5 K to 238.5 K (-2.05 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,496 | 238.5 K to 243.5 K (+2.10 %) |
| May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 70.30 | 302 | 21,232 | 238,496 | 238.2 K to 238.5 K (+0.13 %) |